Skip to main content
TELO
NASDAQ Life Sciences

Telomir Pharmaceuticals Achieves Nasdaq Compliance for Annual Meeting Requirement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.179
Mkt Cap
$39.194M
52W Low
$1.05
52W High
$4.061
52W Position info
12% above low
Off High info
71% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

TELO is trading near its 52-week low of $1.05 (12% above the low).

Summary

Telomir Pharmaceuticals announced it has regained compliance with Nasdaq Listing Rule 5620(a) by holding its 2025 Annual Meeting of Shareholders, resolving a previous deficiency.


Key Events · Corporate Governance and Compliance · TELO

  • Nasdaq Compliance Achieved

    Telomir Pharmaceuticals received notification from Nasdaq Capital Markets confirming compliance with Listing Rule 5620(a) after holding its 2025 Annual Meeting of Shareholders.

  • Deficiency Resolved

    Nasdaq has determined the matter closed, indicating the company has satisfied the requirement to hold an annual meeting.


Analysis · TELO · Life Sciences

This 8-K filing indicates that Telomir Pharmaceuticals has successfully addressed a Nasdaq compliance deficiency related to holding its annual shareholder meeting. While a positive step that removes a potential delisting risk, this is a procedural compliance matter rather than a fundamental change to the company's financial or operational outlook. Investors should note this administrative improvement in the context of the company's ongoing financial challenges, including a recent going concern warning and significant dilution from a recent acquisition.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TELO was trading at $1.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $39.2M. The 52-week trading range was $1.05 to $4.06. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TELO - Latest Insights

TELO
Nov 06, 2026, 4:41 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.740
Real-time Price: $0.750 info
Change: +$0.010 (+1%) info
Market Cap: $52.317M info
TELO
Oct 27, 2026, 4:30 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $1.02
Real-time Price: $0.750 info
Change: -$0.270 (-26%) info
Market Cap: $52.317M info
TELO
Oct 06, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.24
Real-time Price: $0.750 info
Change: -$0.490 (-40%) info
Market Cap: $52.317M info
TELO
Oct 06, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.28
Real-time Price: $0.750 info
Change: -$0.530 (-41%) info
Market Cap: $52.317M info
TELO
Aug 13, 2026, 5:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.05
Real-time Price: $0.750 info
Change: -$0.300 (-29%) info
Market Cap: $52.317M info